Loading financials from SEC filings…
Medical care facilities · Healthcare · Fiscal year ends Dec 31
Pediatrix Medical reported revenue of $1.9B in the fiscal year ended Dec 2025, down 4.9% from the year before. Operating income was $209M, an operating margin of 10.9%, and net income was $165M. Net debt was $195M.
Ranks among the 24 medical care facilities companies we cover (1st = best; for debt, the least indebted). Green = top third, red = bottom third.
Last 5 fiscal years
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1,911 | 1,972 | 1,995 | 2,013 | 1,914 |
| Operating income | 203 | 173 | 7.3 | −68.7 | 209 |
| Interest expense | 68.7 | 39.7 | 42.1 | 40.7 | 36.0 |
| Pre-tax income | 135 | 81.4 | −48.4 | −101 | 216 |
| Income tax | 27.2 | 18.8 | 12.0 | −2.3 | 51.0 |
| Net income | 131 | 66.3 | −60.4 | −99.1 | 165 |
| Diluted EPS | 1.53 | 0.79 | −0.73 | −1.19 | 1.94 |
| Diluted shares | 85.8 | 84.1 | 82.2 | 83.3 | 85.3 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | 387 | 9.8 | 73.3 | 230 | 375 |
| Receivables | 302 | 297 | 272 | 260 | 230 |
| Current assets | 841 | 428 | 483 | 640 | 764 |
| Net PP&E | 70.2 | 73.3 | 75.6 | 39.2 | 39.2 |
| Goodwill | 1,505 | 1,532 | 1,384 | 1,243 | 1,261 |
| Total assets | 2,723 | 2,348 | 2,220 | 2,153 | 2,247 |
| Payables | 36.6 | 31.9 | 34.6 | 46.4 | 37.2 |
| Current liabilities | 427 | 427 | 389 | 434 | 459 |
| Long-term debt | 990 | 637 | 622 | 611 | 571 |
| Total liabilities | 1,826 | 1,456 | 1,371 | 1,388 | 1,381 |
| Shareholders' equity | 896 | 892 | 849 | 765 | 866 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 76.7 | 167 | 137 | 207 | 271 |
| Depreciation & amortisation | 32.1 | 35.6 | 36.2 | 32.2 | 21.8 |
| Stock-based compensation | 19.0 | 16.1 | 12.3 | 11.9 | 18.0 |
| Acquisitions | 29.9 | 28.2 | 6.7 | 8.2 | 23.2 |
| Share buybacks | 4.7 | 88.5 | 0.9 | 1.7 | 86.7 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 3.2% | 1.1% | 0.9% | −4.9% |
| Operating income growth (YoY) | – | −14.9% | −95.8% | −1038.6% | – |
| EPS growth (YoY) | – | −48.4% | −192.4% | – | – |
| Operating margin | 10.6% | 8.8% | 0.4% | −3.4% | 10.9% |
| Net margin | 6.9% | 3.4% | −3.0% | −4.9% | 8.6% |
| Return on equityBlank when equity is negative | 14.6% | 7.4% | −7.1% | −13.0% | 19.1% |
| ROCEEBIT ÷ (assets − current liabilities) | 8.8% | 9.0% | 0.4% | −4.0% | 11.7% |
| Cash conversion (CFO ÷ net income) | 0.59x | 2.52x | −2.27x | −2.09x | 1.64x |
| Receivable days | 58 | 55 | 50 | 47 | 44 |
| Interest cover | 2.95x | 4.35x | 0.17x | −1.69x | 5.81x |
| Debt ÷ equity | 1.10x | 0.71x | 0.73x | 0.80x | 0.66x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | 602 | 627 | 549 | 381 | 195 |
| Current ratio | 1.97x | 1.00x | 1.24x | 1.47x | 1.66x |
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.